ATC codes:
J04AK05
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis
ICD11 code:
ML32.00
INN
Bedaquiline
Medicine type
Chemical agent
List type
Complementary
Additional notes
Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.
Formulations
Oral > Solid:
100 mg tablet ;
20 mg tablet
(EMLc)
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Main patent is active in several jurisdictions. For more information on specific patents and
license status for developing countries visit www.MedsPal.org
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the removal of the age restriction from the listing of bedaquiline on the EML and EMLc, consistent with the recommendations for use of bedaquiline in current WHO guidelines for management of tuberculosis in children and adolescents.